药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Natamycin
Caroverine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Caroverine.
Natamycin
Vinpocetine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Vinpocetine.
Natamycin
Naftopidil
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Naftopidil.
Natamycin
Carboxyamidotriazole
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Carboxyamidotriazole.
Natamycin
Niludipine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Niludipine.
Natamycin
Manidipine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Manidipine.
Natamycin
Darodipine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Darodipine.
Natamycin
Cilnidipine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Cilnidipine.
Natamycin
Azelnidipine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Azelnidipine.
Natamycin
Tolfenamic acid
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Tolfenamic acid.
Natamycin
Agmatine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Agmatine.
Natamycin
Tranilast
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Tranilast.
Natamycin
Dotarizine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Dotarizine.
Natamycin
Nylidrin
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Nylidrin.
Natamycin
Seletracetam
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Seletracetam.
Natamycin
Flunarizine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Flunarizine.
Natamycin
Cyclandelate
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Cyclandelate.
Natamycin
Nimesulide
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Nimesulide.
Natamycin
Fasudil
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Fasudil.
Natamycin
Xylometazoline
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Xylometazoline.